Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 10121-10127
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10121
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10121
CCK group | No CCK group | P value | |
Complications, post-ERCP | 9/103 (8.7) | 10/125 (8.0) | 0.528 |
Pancreatitis (mild) | 4 | 5 | |
Cholangitis (mild) | 4 | 3 | |
Hemobilia (mild) | 1 | 2 | |
Bowel perforation | 0 | 0 | |
Procedure-related mortality | 0 | 0 | |
Complications, post-ESWL | 8/107 (7.5) | 10/127 (7.9) | 0.673 |
Purpuric spots | 5 | 6 | |
Skin ecchymosis | 3 | 4 | |
Splenic rupture | 0 | 0 | |
Lung trauma | 0 | 0 | |
Necrotizing pancreatitis | 0 | 0 | |
Procedure-related mortality | 0 | 0 |
- Citation: Tao T, Zhang QJ, Zhang M, Zhu X, Sun SX, Li YQ. Using cholecystokinin to facilitate endoscopic clearance of large common bile duct stones. World J Gastroenterol 2014; 20(29): 10121-10127
- URL: https://www.wjgnet.com/1007-9327/full/v20/i29/10121.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i29.10121